A Trial to Learn How the Combination of Fianlimab With Cemiplimab and Chemotherapy Works Compared With Cemiplimab and Chemotherapy for Treating Adult Patients With Advanced Non-small Cell Lung Cancer

Clinical trial NCT05800015 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT05800015
Sponsor: Regeneron Pharmaceuticals
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Non-small Cell Lung Cancer

Start date: 2023-08-08
Primary completion: 2030-01-16
Enrollment: 160

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.